Home > Newsletters > Drug Industry Daily > Appeals Court Upholds Exclusion of Purdue Execs; Rejects ‘Arbitrary’ Penalty Period
Drug Industry Daily
July 31, 2012 | Vol. 11 No. 149
Appeals Court Upholds Exclusion of Purdue Execs; Rejects ‘Arbitrary’ Penalty Period
A U.S. appeals court has ruled HHS was “unambiguously” justified in excluding three former Purdue Pharma executives from federal healthcare programs after they pleaded guilty to charges the company illegally marketed and promoted its painkiller Oxycontin.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.